scispace - formally typeset
S

Sheri K. Wilcox

Researcher at Scripps Research Institute

Publications -  47
Citations -  4291

Sheri K. Wilcox is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Aptamer & Systematic evolution of ligands by exponential enrichment. The author has an hindex of 20, co-authored 46 publications receiving 3383 citations. Previous affiliations of Sheri K. Wilcox include University of Colorado Boulder & Pearson Education.

Papers
More filters
Journal ArticleDOI

Aptamer-based multiplexed proteomic technology for biomarker discovery

TL;DR: A versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations, which will enable the discovery of novel biomarkers in a manner that is unencumbered by the incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Journal ArticleDOI

Aptamer-based multiplexed proteomic technology for biomarker discovery

TL;DR: A versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations and will enable the discovery of novel biomarkers in a manner that is unencumbered by the incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Journal ArticleDOI

Expanding the Chemistry of DNA for in Vitro Selection

TL;DR: Six new 5-position modified dUTP derivatives connected by a unique amide linkage were synthesized and tested for compatibility with the enzymatic steps of in vitro selection, resulting in the first successful isolation of DNA aptamers able to bind TNFRSF9 with high affinity.
Journal ArticleDOI

From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay.

TL;DR: It is demonstrated that quantification by microarray-based hybridization, Luminex bead-based methods, and qPCR are each compatible with the SOMAmer platform, further expanding the breadth of proteomic applications for a wide user community.